139 related articles for article (PubMed ID: 36974959)
1. An overview of mechanism and chemical inhibitors of shikimate kinase.
Chagaleti BK; Reddy MBR; Saravanan V; B S; D P; Senthil Kumar P; Kathiravan MK
J Biomol Struct Dyn; 2023; 41(23):14582-14598. PubMed ID: 36974959
[TBL] [Abstract][Full Text] [Related]
2. Identification of shikimate kinase inhibitors among anti-Mycobacterium tuberculosis compounds by LC-MS.
Simithy J; Reeve N; Hobrath JV; Reynolds RC; Calderón AI
Tuberculosis (Edinb); 2014 Mar; 94(2):152-8. PubMed ID: 24429106
[TBL] [Abstract][Full Text] [Related]
3. Benzothiazole Derivative as a Novel Mycobacterium tuberculosis Shikimate Kinase Inhibitor: Identification and Elucidation of Its Allosteric Mode of Inhibition.
Mehra R; Rajput VS; Gupta M; Chib R; Kumar A; Wazir P; Khan IA; Nargotra A
J Chem Inf Model; 2016 May; 56(5):930-40. PubMed ID: 27149193
[TBL] [Abstract][Full Text] [Related]
4. Shikimate kinase, a protein target for drug design.
Coracini JD; de Azevedo WF
Curr Med Chem; 2014; 21(5):592-604. PubMed ID: 24164195
[TBL] [Abstract][Full Text] [Related]
5. Effects of the magnesium and chloride ions and shikimate on the structure of shikimate kinase from Mycobacterium tuberculosis.
Dias MV; Faím LM; Vasconcelos IB; de Oliveira JS; Basso LA; Santos DS; de Azevedo WF
Acta Crystallogr Sect F Struct Biol Cryst Commun; 2007 Jan; 63(Pt 1):1-6. PubMed ID: 17183161
[TBL] [Abstract][Full Text] [Related]
6. Structure-based in silico design of a high-affinity dipeptide inhibitor for novel protein drug target Shikimate kinase of Mycobacterium tuberculosis.
Kumar M; Verma S; Sharma S; Srinivasan A; Singh TP; Kaur P
Chem Biol Drug Des; 2010 Sep; 76(3):277-84. PubMed ID: 20626408
[TBL] [Abstract][Full Text] [Related]
7. Screening of antitubercular compound library identifies novel shikimate kinase inhibitors of Mycobacterium tuberculosis.
Rajput VS; Mehra R; Kumar S; Nargotra A; Singh PP; Khan IA
Appl Microbiol Biotechnol; 2016 Jun; 100(12):5415-26. PubMed ID: 26887318
[TBL] [Abstract][Full Text] [Related]
8. Shikimate kinase (EC 2.7.1.71) from Mycobacterium tuberculosis: kinetics and structural dynamics of a potential molecular target for drug development.
Saidemberg DM; Passarelli AW; Rodrigues AV; Basso LA; Santos DS; Palma MS
Curr Med Chem; 2011; 18(9):1299-310. PubMed ID: 21366533
[TBL] [Abstract][Full Text] [Related]
9. Identification of novel scaffold using ligand and structure based approach targeting shikimate kinase.
Rahul Reddy MB; Krishnasamy SK; Kathiravan MK
Bioorg Chem; 2020 Sep; 102():104083. PubMed ID: 32745735
[TBL] [Abstract][Full Text] [Related]
10. Crystallographic studies of shikimate binding and induced conformational changes in Mycobacterium tuberculosis shikimate kinase.
Dhaliwal B; Nichols CE; Ren J; Lockyer M; Charles I; Hawkins AR; Stammers DK
FEBS Lett; 2004 Sep; 574(1-3):49-54. PubMed ID: 15358538
[TBL] [Abstract][Full Text] [Related]
11. Mycobacterium tuberculosis shikimate kinase inhibitors: design and simulation studies of the catalytic turnover.
Blanco B; Prado V; Lence E; Otero JM; Garcia-Doval C; van Raaij MJ; Llamas-Saiz AL; Lamb H; Hawkins AR; González-Bello C
J Am Chem Soc; 2013 Aug; 135(33):12366-76. PubMed ID: 23889343
[TBL] [Abstract][Full Text] [Related]
12. Synthesis, molecular docking, and biological evaluation of novel 1,2,4-triazole-isatin derivatives as potential Mycobacterium tuberculosis shikimate kinase inhibitors.
Dadlani VG; Chhabhaiya H; Somani RR; Tripathi PK
Chem Biol Drug Des; 2022 Aug; 100(2):230-244. PubMed ID: 35434882
[TBL] [Abstract][Full Text] [Related]
13. Shikimate Kinase Inhibitors: An Update on Promising Strategy against
Rajput VS; Runthala A; Khan IA
Curr Drug Targets; 2023; 24(5):388-405. PubMed ID: 36752299
[TBL] [Abstract][Full Text] [Related]
14. Interaction of shikimic acid with shikimate kinase.
Pereira JH; de Oliveira JS; Canduri F; Dias MV; Palma MS; Basso LA; de Azevedo WF; Santos DS
Biochem Biophys Res Commun; 2004 Dec; 325(1):10-7. PubMed ID: 15522194
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of Shikimate Kinase from Methicillin-Resistant
Rios-Soto L; Hernández-Campos A; Tovar-Escobar D; Castillo R; Sierra-Campos E; Valdez-Solana M; Téllez-Valencia A; Avitia-Domínguez C
Int J Mol Sci; 2024 May; 25(10):. PubMed ID: 38791117
[TBL] [Abstract][Full Text] [Related]
16. Structures of Helicobacter pylori shikimate kinase reveal a selective inhibitor-induced-fit mechanism.
Cheng WC; Chen YF; Wang HJ; Hsu KC; Lin SC; Chen TJ; Yang JM; Wang WC
PLoS One; 2012; 7(3):e33481. PubMed ID: 22438938
[TBL] [Abstract][Full Text] [Related]
17. Structure of shikimate kinase from Mycobacterium tuberculosis reveals the binding of shikimic acid.
Pereira JH; de Oliveira JS; Canduri F; Dias MV; Palma MS; Basso LA; Santos DS; de Azevedo WF
Acta Crystallogr D Biol Crystallogr; 2004 Dec; 60(Pt 12 Pt 2):2310-9. PubMed ID: 15583379
[TBL] [Abstract][Full Text] [Related]
18. Identification of new potential Mycobacterium tuberculosis shikimate kinase inhibitors through molecular docking simulations.
Vianna CP; de Azevedo WF
J Mol Model; 2012 Feb; 18(2):755-64. PubMed ID: 21594693
[TBL] [Abstract][Full Text] [Related]
19. Shikimate kinase: a potential target for development of novel antitubercular agents.
Pereira JH; Vasconcelos IB; Oliveira JS; Caceres RA; de Azevedo WF; Basso LA; Santos DS
Curr Drug Targets; 2007 Mar; 8(3):459-68. PubMed ID: 17348838
[TBL] [Abstract][Full Text] [Related]
20. Structure of shikimate kinase, an in vivo essential metabolic enzyme in the nosocomial pathogen Acinetobacter baumannii, in complex with shikimate.
Sutton KA; Breen J; MacDonald U; Beanan JM; Olson R; Russo TA; Schultz LW; Umland TC
Acta Crystallogr D Biol Crystallogr; 2015 Aug; 71(Pt 8):1736-44. PubMed ID: 26249354
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
